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Pertussis toxin (PTX), a Bordetella Pertussis exotoxin, has
been recently shown to prevent growth factor-induced
activation of the extracellular signal regulated protein
kinases ERK1 and ERK2. Due to its capacity to ribosylate
inhibitory GTP-binding proteins of the Gi/o family, the
antiproliferative effect of PTX is generally thought to orig-
inate form interference with growth factor receptor-
induced inhibitory signal transduction pathways. How-
ever, in human embryonic kidney (HEK293) cells, we
could recently demonstrate that attenuation of inhibitory
Gi/o signaling by the regulator protein Goloco failed to
affect epidermal growth factor (EGF) receptor-induced
ERK1/2 activation. In addition, Goloco also failed to
interfere insulin-like growth factor (IGF-1) receptor asso-
ciated ERK1/2 signaling, indicating that PTX must affect
ERK1/2 signalling by mechanism other than inactivation
of Gi/o function. The small GTP-binding protein p21ras
plays a central role in mitogenic signalling, as it connects
a number of growth factor receptors to the raf-1/MEK/
ERK1/2 signalling module. Western blot experiments
revealed that pre-treatment of HEK293 cells with PTX pre-
vents translocation of p21ras to the plasma membranes.
Moreover, immune-precipitation experiments also
showed that PTX prevents interaction of p21ras with raf-1
kinase. A similar finding was observed after pre-treatment
of the cells with mevastatin, a 3-hydroxy-3-methylglutaryl
coenzyme A reductase inhibitor. Mevastatin treatment
resulted in a loss of p21ras from the plasma membrane,
inhibited EGF-induced p21ras/raf-1 interaction and
ERK1/2 activation. These results indicate that, besides of
its inhibitory action on Gi/o signalling pathways, PTX
may also interfere with growth factor-mediated ERK1/2
activation by attenuating p21ras activation.
from 12th Joint Meeting of the Signal Transduction Society (STS). Signal Transduction: Receptors, Mediators and Genes
Weimar, Germany. 29–31 October 2008
Published: 26 February 2009
Cell Communication and Signaling 2009, 7(Suppl 1):A44 doi:10.1186/1478-811X-7-S1-A44
<supplement> <title> <p>12th Joint Meeting of the Signal Transduction Society (STS). Signal Transduction: Receptors, Mediators and Genes</p> </title> <editor>Frank Entschladen, Karlheinz Friedrich, Ralf Hass and Ottmar Janssen</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1478-811X-7-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.biosignaling.com/content/7/S1/A44
© 2009 Eisinger and Ammer; licensee BioMed Central Ltd. 
